28 false false false false false false false false false false true false false false false true true true true No description of principal activity 2024-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 250,000 250,000 23,573 2,166 21,407 xbrli:pure xbrli:shares iso4217:GBP 10469285 2024-05-01 2025-04-30 10469285 2025-04-30 10469285 2024-04-30 10469285 2023-05-01 2024-04-30 10469285 2024-04-30 10469285 2023-04-30 10469285 core:NetGoodwill 2024-05-01 2025-04-30 10469285 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 10469285 bus:OrdinaryShareClass2 2024-05-01 2025-04-30 10469285 bus:OrdinaryShareClass3 2024-05-01 2025-04-30 10469285 bus:Director1 2024-05-01 2025-04-30 10469285 bus:Director2 2024-05-01 2025-04-30 10469285 core:WithinOneYear 2025-04-30 10469285 core:WithinOneYear 2024-04-30 10469285 core:NetGoodwill 2024-04-30 10469285 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-30 10469285 core:NetGoodwill 2025-04-30 10469285 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-04-30 10469285 core:FurnitureFittings 2024-04-30 10469285 core:FurnitureFittings 2025-04-30 10469285 core:FurnitureFittings 2024-05-01 2025-04-30 10469285 core:ShareCapital 2025-04-30 10469285 core:ShareCapital 2024-04-30 10469285 core:RetainedEarningsAccumulatedLosses 2025-04-30 10469285 core:RetainedEarningsAccumulatedLosses 2024-04-30 10469285 core:BetweenOneFiveYears 2025-04-30 10469285 core:BetweenOneFiveYears 2024-04-30 10469285 core:DeferredTaxation 2024-05-01 2025-04-30 10469285 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-05-01 2025-04-30 10469285 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-30 10469285 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 10469285 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2025-04-30 10469285 core:AcceleratedTaxDepreciationDeferredTax 2025-04-30 10469285 core:AcceleratedTaxDepreciationDeferredTax 2024-04-30 10469285 core:FurnitureFittings 2024-04-30 10469285 core:DeferredTaxation 2024-04-30 10469285 core:DeferredTaxation 2025-04-30 10469285 bus:SmallEntities 2024-05-01 2025-04-30 10469285 bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 10469285 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 10469285 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 10469285 bus:FullAccounts 2024-05-01 2025-04-30 10469285 bus:OrdinaryShareClass1 2025-04-30 10469285 bus:OrdinaryShareClass1 2024-04-30 10469285 bus:OrdinaryShareClass2 2025-04-30 10469285 bus:OrdinaryShareClass2 2024-04-30 10469285 bus:OrdinaryShareClass3 2025-04-30 10469285 bus:OrdinaryShareClass3 2024-04-30 10469285 bus:AllOrdinaryShares 2025-04-30 10469285 bus:AllOrdinaryShares 2024-04-30 10469285 core:ComputerEquipment 2024-04-30 10469285 core:ComputerEquipment 2024-05-01 2025-04-30 10469285 core:ComputerEquipment 2025-04-30 10469285 bus:ChairmanChiefExecutive 2024-05-01 2025-04-30
COMPANY REGISTRATION NUMBER: 10469285

BSN Associates Limited

Filleted Unaudited Financial Statements

30 April 2025

BSN Associates Limited

Statement of Financial Position

30 April 2025

| 2025 | 2024
Note | £ | £

Fixed assets

Intangible assets | 5 | 10,721 | 16,085
Tangible assets | 6 | 150,584 | 173,073
| --------- | ---------
| 161,305 | 189,158

Current assets

Debtors | 8 | 524,970 | 388,959
Cash at bank and in hand | 124,513 | 115,838
| --------- | ---------
| 649,483 | 504,797

Creditors: amounts falling due within one year | 9 | 449,190 | 423,598
| --------- | ---------
Net current assets | 200,293 | 81,199
| --------- | ---------
Total assets less current liabilities | 361,598 | 270,357

Provisions | 10 | 21,407 | 23,573
| --------- | ---------
Net assets | 340,191 | 246,784
| --------- | ---------

Capital and reserves

Called up share capital | 12 | 20,000 | 20,000
Profit and loss account | 320,191 | 226,784
| --------- | ---------
Shareholders funds | 340,191 | 246,784
| --------- | ---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

BSN Associates Limited

Statement of Financial Position (continued)

30 April 2025
These financial statements were approved by the board of directors and authorised for issue on 4 August 2025 , and are signed on behalf of the board by:

H E Justice | P D Miller-Hawkes
Director | Director

Company registration number: 10469285

BSN Associates Limited

Notes to the Financial Statements

Year ended 30 April 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 3B Swallowfield Courtyard, Wolverhampton Road, Oldbury, West Midlands, B69 2JG.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. As such, advantage has been taken of the following disclosure exemptions available under FRS 102: (a) Disclosures in respect of each class of share capital have not been presented. (b) No cash flow statement has been presented for the company. (c) Disclosures in respect of financial instruments have not been presented.
Consolidation
The entity has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the entity and its subsidiary undertakings comprise a small group.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The judgements (apart from those involving estimations) that management has made in the process of applying the entity's accounting policies and that have the most significant effect on the amounts recognised in the financial statements are those relating to revenue recognition. Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. There are no key assumptions and other sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax. Services rendered are the total of bills submitted for completed asssignments, together with amounts included in debtors representing the right to receive consideration where some but not all of the contractual obligations of the company to its clients have been fulfilled.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

| Goodwill | - | 2 years straightline or immediate write off
| Development costs | - | 5 years straightline

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Research and development
Research expenditure is written off in the period in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met: - It is technically feasible to complete the intangible asset so that it will be available for use or sale; - There is the intention to complete the intangible asset and use or sell it; - There is the ability to use or sell the intangible asset; - The use or sale of the intangible asset will generate probable future economic benefits; - There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and - The expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Fixtures and fittings | - | 10 years straight line
| Equipment | - | 3 - 10 years staright line

Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 28 (2024: 29 ).
5. Intangible assets

| Goodwill | Development costs | Total
| £ | £ | £
Cost |  |  |
At 1 May 2024 and 30 April 2025 | 390,311 | 26,813 | 417,124
| --------- | -------- | ---------
Amortisation |  |  |
At 1 May 2024 | 390,311 | 10,728 | 401,039
Charge for the year | – | 5,364 | 5,364
| --------- | -------- | ---------
At 30 April 2025 | 390,311 | 16,092 | 406,403
| --------- | -------- | ---------
Carrying amount |  |  |
At 30 April 2025 | – | 10,721 | 10,721
| --------- | -------- | ---------
At 30 April 2024 | – | 16,085 | 16,085
| --------- | -------- | ---------

6. Tangible assets

| Fixtures and fittings | Equipment | Total
| £ | £ | £
Cost |  |  |
At 1 May 2024 | 196,606 | 50,602 | 247,208
Additions | – | 4,332 | 4,332
Disposals | – | ( 9,708) | ( 9,708)
| --------- | -------- | ---------
At 30 April 2025 | 196,606 | 45,226 | 241,832
| --------- | -------- | ---------
Depreciation |  |  |
At 1 May 2024 | 32,057 | 42,078 | 74,135
Charge for the year | 19,412 | 7,352 | 26,764
Disposals | – | ( 9,651) | ( 9,651)
| --------- | -------- | ---------
At 30 April 2025 | 51,469 | 39,779 | 91,248
| --------- | -------- | ---------
Carrying amount |  |  |
At 30 April 2025 | 145,137 | 5,447 | 150,584
| --------- | -------- | ---------
At 30 April 2024 | 164,549 | 8,524 | 173,073
| --------- | -------- | ---------

7. Investments

| Shares in group undertakings
| £
Cost |
At 1 May 2024 and 30 April 2025 | 250,000
| ---------
Impairment |
At 1 May 2024 and 30 April 2025 | 250,000
| ---------

Carrying amount |
At 30 April 2025 | –
| ---------
At 30 April 2024 | –
| ---------

8. Debtors

| 2025 | 2024
| £ | £
Trade debtors | 258,677 | 188,883
Prepayments and accrued income | 266,293 | 198,731
Other debtors | – | 1,345
| --------- | ---------
| 524,970 | 388,959
| --------- | ---------

9. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Trade creditors | 28,798 | 48,323
Accruals and deferred income | 94,628 | 105,982
Corporation tax | 135,120 | 91,772
Social security and other taxes | 81,205 | 50,765
Director loan accounts | 97,592 | 120,637
Other creditors | 11,847 | 6,119
| --------- | ---------
| 449,190 | 423,598
| --------- | ---------

10. Provisions

| Deferred tax (note 11)
| £
At 1 May 2024 | 23,573
Charge against provision | ( 2,166)
| --------
At 30 April 2025 | 21,407
| --------

11. Deferred tax
The deferred tax included in the statement of financial position is as follows:

| 2025 | 2024
| £ | £
Included in provisions (note 10) | 21,407 | 23,573
| -------- | --------

The deferred tax account consists of the tax effect of timing differences in respect of:

| 2025 | 2024
| £ | £
Accelerated capital allowances | 21,407 | 23,573
| -------- | --------

12. Called up share capital
Issued, called up and fully paid

| 2025 | 2024
| No. | £ | No. | £
A Ordinary shares of £ 1 each | 5,000 | 5,000 | 5,000 | 5,000
B Ordinary shares of £ 1 each | 5,000 | 5,000 | 5,000 | 5,000
C Ordinary shares of £ 1 each | 10,000 | 10,000 | 10,000 | 10,000
| -------- | -------- | -------- | --------
| 20,000 | 20,000 | 20,000 | 20,000
| -------- | -------- | -------- | --------

13. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:

| 2025 | 2024
| £ | £
Not later than 1 year | 55,000 | 55,000
Later than 1 year and not later than 5 years | 9,167 | 64,167
| -------- | ---------
| 64,167 | 119,167
| -------- | ---------

14. Directors' advances, credits and guarantees
The amount owed to directors at the end of the year was £97,592 (2024:£120,637).
15. Controlling party
The company's ultimate parent undertaking in the current year and previous year was BSN Group Limited, a company registered in England & Wales and controlled by H E Justice and P D Miller-Hawkes .